AL
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study | Child and adolescent psychiatry and mental health | 2023 | 60 | 33 | |||
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021) : a longitudinal study in Switzerland | International journal for equity in health | 2023 | 25 | 4 | |||
Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic : An intersectional analysis | SSM, population health | 2023 | 53 | 20 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | 2023 | 54 | 46 | |||
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study | Infection | 2023 | 21 | 4 | |||
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications | 2023 | 82 | 18 | |||
Development of hybrid immunity during a period of high incidence of Omicron infections | International journal of epidemiology | 2023 | 27 | 5 | |||
Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 93 | 60 | |||
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents | Nature communications | 2022 | 134 | 23 | |||
COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 34 | 14 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | 2021 | 169 | 70 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases | 2021 | 198 | 120 | |||
Detection of Spatiotemporal Clusters of COVID-19–Associated Symptoms and Prevention Using a Participatory Surveillance App: Protocol for the @choum Study | JMIR research protocols | 2021 | 120 | 50 |